gip/glp 1-agonist tirzepatide SEMA vs TIRZ vs RETA — the 3 GLP-1s everyone's comparing, side by side. Save this one. 🧬 The whole thing comes down to one idea: how many receptors each drug pulls Targeting GLP-1, GIP & GCG

The TRANSCEND-T2D-1 trial demonstrated A1C reductions of up to 2.0% and weight loss of up to 16.8% at 40 weeks, with no plateau observed through the end of the treatment period

Ambulatory blood pressure reduction with SGLT-2 inhibitors: dose-response meta-analysis and comparative evaluation with low-dose hydrochlorothiazide

or Imply FDA approval, clearance, or clinical evaluation or otherwise misrepresent the source or regulatory status of the product Compounding Practices Organizations involved in dispensing or coordinating compounded medications should evaluate whether compounding is performed pursuant to patient-specific prescriptions and the activity aligns with federal compounding requirements

Helps manage photodamage Promotes skin radiance

And it is likely that the cost of making those improvements will be hither that the return we will obtain